Theranos Pitch Deck Breakdown [Let's Decode]

Our client Shawn asked us an interesting question while we were making their pitch deck:

“Despite what happened with Theranos, is their pitch deck worth looking at?”

Our Creative Director answered immediately:

“Yes, but only if you know what you’re looking for.”

As a presentation design agency, we work on many pitch decks throughout the year, and in the process, we’ve observed one common challenge: people often mistake storytelling for selling. They assume that if the story is compelling enough, it will carry the entire pitch. But a pitch deck is more than just a story. It’s an alignment of story, numbers, design, and credibility.

So, in this blog, we’ll talk about what we can actually learn from the Theranos pitch deck, why it worked in the room despite being flawed, and what lessons you should (and should not) take away when you build your own.

In case you didn't know, we specialize in only one thing: making presentations. We can help you by designing your slides and writing your content too.

Why You Should Care About the Theranos Pitch Deck

Let’s put this out clearly: what Theranos promised and what they delivered turned out to be two very different things. The company collapsed because the science wasn’t real. The credibility went out the window the moment people realized the tech didn’t work.

So why are we even bothering to talk about the Theranos pitch deck?

Because when we look at this deck, we’re not looking at it from a credibility point of view. We’re not analyzing whether their claims were honest or their projections realistic. That part of the story has been told and retold enough. What we’re decoding here is the structure of the story they built and how it was presented in the pitch deck.

And that’s worth paying attention to.

Most founders today obsess over their numbers, market size, or tech demo. They forget that the pitch deck isn’t just a collection of data points. It’s a narrative tool. Investors don’t just fund businesses, they fund stories they can believe in.

The Theranos pitch deck—despite being tied to one of the biggest scandals in startup history—shows us how a well-structured story can move a room, even when the underlying product doesn’t back it up. And as much as it hurts to admit, there are lessons here for anyone who wants to get better at crafting a pitch.

The point is not to copy Theranos. The point is to study why their pitch landed in the first place, and then take those structural elements into your own deck while building them on a foundation of truth and credibility.

Theranos Pitch Deck Breakdown

Here's the Theranos Pitch Deck for your reference...

When you first glance at the Theranos pitch deck, it feels like a pretty standard startup deck. Nothing extraordinary in terms of visuals. Nothing flashy. Just text, logos, images, and some very strategic structuring. And yet, it worked in the room. Investors bought into it. So let’s break it down slide by slide—not to glorify it, but to decode how the story was built.

1. Title Slide

The very first slide is as ordinary as it gets: the Theranos logo, the company name, and a small line—“a presentation for investors.”

Now, this may look underwhelming, but that’s exactly the point. The title slide sets the tone.

Theranos didn’t try to be clever or artsy here. Instead, it communicated one thing: we’re serious. No gimmicks, no fireworks. Just “this is our company, this is our pitch.” If you’ve ever sat in on investor meetings, you’ll know how much they dislike fluff in the first minute. They want to know: who are you, and why are you here? Theranos checked that box with a straightforward opening.

2. Company Details and Vision

Right after the title, the deck moved straight into the company’s identity: when it was founded, what it stood for, and what it planned to build. This included a vision statement and its product platform, along with its entry point into the market—Phase IV clinical trials.

Here’s what’s clever about this structure: they didn’t overwhelm the audience with science right away. Instead, they told you what they wanted to be in the world. Vision first, product later. Investors aren’t buying the technical jargon; they’re buying the dream. And Theranos framed themselves as a company positioned to transform healthcare.

3. “Theranos Today” Snapshot

This slide essentially said: we’re not just an idea. We already exist.

It listed six deals they had closed, revenue projections, ten companies they were working with, one government agency, and a summary of existing deals and their revenue.

Why was this important? Because traction is the antidote to skepticism. Investors have heard a million “what ifs” from early-stage startups. What they want is evidence. By saying “here’s who we’re already working with,” Theranos turned the conversation from speculative to concrete. It’s the startup equivalent of “don’t just take my word for it, look at the people already betting on us.”

4. Management and Board of Directors

This was perhaps one of the most powerful slides in the deck. Theranos listed their management team and board of directors. The names were big. Politicians, military leaders, industry veterans. People with credibility that money can’t easily buy.

For any investor, seeing high-profile names on the board signals two things: one, this startup has influence; two, if these people are backing it, there must be something real here. It’s social proof at scale.

This slide is where the deck really punched above its weight. Even if you had doubts about the product, the presence of heavyweight directors reassured you. That’s the psychology behind it.

5. Images of the System

The next move was visual. Instead of burying investors in technical jargon, Theranos showed them images of the actual system. Seeing the device mattered. It made the technology tangible.

And this is a crucial lesson for founders: when your product feels intangible, investors struggle to believe it exists. Show it to them. Make it real. Even if it’s a prototype, even if it doesn’t work perfectly yet, visuals anchor belief. Theranos did this smartly.

6. Diagram of the Technology

After showing the device, the deck introduced a diagram that explained how the technology supposedly worked.

Now, most investors aren’t scientists. They didn’t need to understand every technical detail. They just needed to believe the mechanism had logic behind it. The diagram gave them that. It was storytelling in scientific clothing. A visual that said: here’s the engine behind the promise.

7. Product Features

Once the audience had a picture of the system and a diagram of how it worked, Theranos layered on the features. Speed, accuracy, convenience, low cost—this was the laundry list of why their device was superior.

Notice the sequencing: vision, traction, credibility, system, mechanism, and only then features. If they had started with features, the impact would have been flat. Features don’t inspire. But once you’ve already bought into the dream, features feel like proof that the dream has substance.

8. Value Proposition

This slide connected the dots. Why does this product matter? What problem does it solve better than anyone else?

For Theranos, the value proposition was massive: accurate blood testing with just a finger prick, at a fraction of the cost and time. Investors didn’t need to imagine why that mattered. The value was obvious.

When you’re crafting your own deck, remember this: your value proposition should not need paragraphs of explanation. It should click instantly. Theranos nailed that part.

9. Market Size and Estimations

Here’s where the deck shifted gears into numbers. Investors love a big market. And Theranos gave them one. Healthcare is a multi-trillion-dollar industry, and diagnostics sits right at the center of it.

They didn’t just say “the market is huge.” They broke down estimations and projections, showing exactly where their solution could slot in. This is what investors want to see: not just a big pie, but proof that you know where your slice will come from.

10. Total Addressable Market (TAM)

Building on the market size slide, Theranos zoomed in further. They quantified their TAM—the revenue opportunity available if they captured their target segment.

Why does this matter? Because market size without TAM is just noise. TAM tells investors how much money is realistically up for grabs. It bridges the gap between dreaming and strategizing.

11. Pains in the Existing Marketplace

Next, the deck reminded investors why the current system was broken. Long wait times, high costs, painful processes, delayed results—the list of pains was clear.

This slide was critical because it set the stage for their solution. If you want your audience to crave your product, you first have to make them feel the frustration of living without it. Theranos did this by shining a light on everything wrong with existing diagnostics.

12. The Theranos Solution

Only after outlining the pain did the deck present the cure: the Theranos system. Fast, painless, cost-effective testing that promised to solve all the headaches investors had just been reminded of.

This is storytelling 101. First the problem, then the hero. It’s simple, but when done right, it’s effective.

13. Drivers for Success

Here, Theranos listed the reasons they would win: cutting-edge technology, influential leadership, strategic partnerships, massive market demand.

The psychology behind this slide is straightforward. Investors don’t just want a good product; they want confidence that you can dominate. By listing drivers for success, Theranos showed that their odds weren’t just good—they were inevitable.

14. The Offering

This was the slide where Theranos told investors what they were actually raising: the structure of their investment round, how much money they wanted, and what it would be used for.

Every good pitch deck needs this. You can’t just excite investors without giving them a clear way to get involved. The offering slide makes the ask explicit.

15. Existing Investor Profiles (Series A and Series B)

Finally, the deck closed with a power move: a list of the investors who had already backed them. Series A and B investors with recognizable names.

Why does this work? Because it’s the final push of social proof. It tells new investors: “You won’t be the first to bet on us, and you won’t be the last. Look at the people already in the room.”

It’s human psychology again. Nobody wants to miss out on the party that everyone else is already at.

Taken together, this structure is what made the Theranos pitch deck so persuasive. It wasn’t the design. It wasn’t the science. It was the sequencing of the story: vision, traction, credibility, visuals, features, value, market, pain, solution, drivers, ask, and social proof.

That order matters. Get it wrong, and your pitch feels scattered. Get it right, and you can hold attention even if your product isn’t perfect. And that’s the uncomfortable but important lesson from Theranos: story sells, even when reality doesn’t.

---

Why Hire Us to Build your Presentation?

If you're reading this, you're probably working on a presentation right now. You could do it all yourself. But the reality is - that’s not going to give you the high-impact presentation you need. It’s a lot of guesswork, a lot of trial and error. And at the end of the day, you’ll be left with a presentation that’s “good enough,” not one that gets results. On the other hand, we’ve spent years crafting thousands of presentations, mastering both storytelling and design. Let us handle this for you, so you can focus on what you do best.

---

Explore Case Studies | Get to Know Us | Start Your Project